MUC5AC and rheumatoid arthritis: Two glycosylated proteins, MUC3 and MUC5AC, play a role in the angiogenesis mechanism of RA, suggesting that novel pharmacological strategies targeting glycosylation can be used to reduce excessive angiogenesis in pathological conditions.